Cancer News and Research

Latest Cancer News and Research

ChromoCure's aneuploidy theory of cancer further validated

ChromoCure, Inc. -- The Company announces that its long-held theory of cancer, aneuploidy, has been further validated by a study published in the January 15, 2010 issue of Cancer Research (Volume 70, Issue 2).

21 Jan 2010

RMC selects Allscripts EDIS to improve access to clinical information

Allscripts announced today that Northeast Alabama Regional Medical Center (RMC) has selected the Allscripts Emergency Department Information System (EDIS) to automate emergency operations and improve access to clinical information.

21 Jan 2010

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

pSivida Corp., a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr. Paul Ashton, will discuss ocular drug delivery in diabetic retinopathy during a presentation at the 6th Annual Diabetes Conference in London, on Friday, January 22.

21 Jan 2010

IMUC’s ICT-107 vaccine product candidate targets cancer stem cells

ImmunoCellular Therapeutics today announced the results of a study in which it was shown that certain specific antigens are highly expressed on cancer stem cells (CSCs). This suggests that IMUC’s lead cancer vaccine product candidate ICT-107, which targets those antigens, may effectively target not only the cells that make up the bulk of certain cancerous tumors, but also the CSCs that are widely believed to give rise to them and cause their recurrence.

21 Jan 2010

Discovery of new class of compounds may help fight hepatitis C

Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.

21 Jan 2010

Study identifies new mechanism that causes allergic response in people

WHAT: A new study in human cells has singled out a molecule that specifically directs immune cells to develop the capability to produce an allergic response. The signaling molecule, called thymic stromal lymphopoietin (TSLP), is key to the development of allergic diseases such as asthma, atopic dermatitis (eczema) and food allergy.

21 Jan 2010

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Stem Cell Assurance, Inc. announced today that Arthur Handal, MD., F.A.C.S. has performed the first regenerative cell breast augmentation through its nationwide physician network. The procedure was performed at Handal Plastic Surgery in Boca Raton, Florida in the practice's onsite accredited ambulatory surgical facility.

21 Jan 2010

Medco Health Solutions launches Medco TRC for oncology patients

Medco Health Solutions, Inc. today announced the launch of the Medco Therapeutic Resource Center® (TRC) for oncology patients headquartered in Whitestown, Ind., where specialist pharmacists will manage the company's more than 850,000 patients currently living with cancer, one of the fastest growing segments of healthcare.

21 Jan 2010

Dosing in First-in-Man Phase I study of 4SC AG's 4SC-203 commenced

4SC AG, a drug discovery and development company, today announced the start of dosing in a First-in-Man Phase I study in healthy volunteers evaluating 4SC-203, a novel multi-target kinase inhibitor, with particular specificity against selected kinases, including FMS-like tyrosine kinase 3 (FLT3), FLT3 mutants and vascular endothelial growth factor receptors (VEGF-R).

21 Jan 2010

Tel Aviv University finds estrogen may protect women from psychosis

Many American women are prescribed estrogen to combat the negative effects of menopause, such as bone loss and mood swings. Now, new evidence from a Tel Aviv University study suggests that hormone replacement therapy might also protect them ― and younger women ― from schizophrenia as well.

21 Jan 2010

Research shows brain abnormalities develop years before Parkinson's symptoms appear

Scientists who have identified brain networks damaged in Parkinson's disease have new evidence that these systems become abnormal a few years before symptoms appear. And what's more, parts of the network appear to respond in a last ditch attempt to rescue the brain.

21 Jan 2010

AMAG Pharmaceuticals prices public offering of common stock

AMAG Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 3,600,000 shares of its common stock at a price to the public of $48.25 per share.

21 Jan 2010

College of American Pathologists unveils resources and features on cancer in MyBiopsy.org

There's nothing more frightening than hearing the words "you have cancer" from your physician. With this diagnosis, many questions come to mind ... What's next? Will I survive? How do I tell my loved ones? The last is the most important for many people after receiving a cancer diagnosis: I need accurate information right now.

21 Jan 2010

Research provides new insights on VEGF receptor function

Researchers at the University of Helsinki, Finland, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, have determined the crystal structure of the ligand binding domain of a vascular endothelial growth factor (VEGF) receptor in complex with one of its ligands (VEGF-C).

21 Jan 2010

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

First Coast Oncology in Jacksonville, Florida has significantly enhanced its ability to treat breast cancer with the addition of a Naviscan PEM (Positron Emission Mammography) scanner.

20 Jan 2010

New study may help develop assessment tests in social-emotional learning

Neurobehavioral researchers at Rush University Medical Center have found three key factors in a child's behavior that can lead to social rejection. The studies are a crucial step in developing scientifically sound screening tests and treatment planning for social-emotional learning difficulties.

20 Jan 2010

Ambry Genetics introduces new StemArray product and services utilizing aCGH technology

Ambry Genetics today introduces their new StemArray™ product and services utilizing aCGH technology to cover the entire genome. The Ambry StemArray™ offers a higher resolution approach to standard karyotyping for stem cells at comparable costs.

20 Jan 2010

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Kolltan Pharmaceuticals, Inc., a next-generation oncology therapeutics company, announced today that it has raised $10 million in investments and related payments from an affiliate of Celtic Therapeutics Holdings L.P. (“Celtic Therapeutics”) and Tichenor Ventures, LLC.

20 Jan 2010

MedPage Today publishes the Most Read Stories for the Past Week

Which medical news stories are physicians reading to stay informed about key developments? MedPage Today publishes the Most Read Stories for the Past Week.

20 Jan 2010

Modern healthcare in Tri-Cities offers bright economic future and improved quality of life

Reliable, modern healthcare is Tri-Cities, Tennessee's "ace in the hole" when it comes to future economic development and improved quality of life.

20 Jan 2010

Cancer News and Research

Latest Cancer News and Research

ChromoCure's aneuploidy theory of cancer further validated

RMC selects Allscripts EDIS to improve access to clinical information

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

IMUC’s ICT-107 vaccine product candidate targets cancer stem cells

Discovery of new class of compounds may help fight hepatitis C

Study identifies new mechanism that causes allergic response in people

Stem Cell Assurance performs first regenerative cell breast augmentation surgery

Medco Health Solutions launches Medco TRC for oncology patients

Dosing in First-in-Man Phase I study of 4SC AG's 4SC-203 commenced

Tel Aviv University finds estrogen may protect women from psychosis

Research shows brain abnormalities develop years before Parkinson's symptoms appear

AMAG Pharmaceuticals prices public offering of common stock

College of American Pathologists unveils resources and features on cancer in MyBiopsy.org

Research provides new insights on VEGF receptor function

First Coast Oncology uses PEM scanner and AccuBoost image guided procedure for breast cancer treatment

New study may help develop assessment tests in social-emotional learning

Ambry Genetics introduces new StemArray product and services utilizing aCGH technology

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

MedPage Today publishes the Most Read Stories for the Past Week

Modern healthcare in Tri-Cities offers bright economic future and improved quality of life

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in